Mereo BioPharma Group plc cotiza a 0.32 USD y tiene una capitalización bursátil de $51M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase …
| Periodo | 2026-11 | 2026-08 | 2026-08 | 2026-05 |
|---|---|---|---|---|
| Real | — | — | $-0.01 | $-0.01 |
| Estimado | $-0.01 | $-0.01 | $-0.01 | — |
| Sorpresa | — | — | +0.0% | — |
| Métrica | MREO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -8021.4% | -38.6% | -7982.8% |
| Net Margin | -8375.6% | -33.6% | -8342.0% |
| FCF Margin | -6198.2% | -13.9% | -6184.3% |
| ROE | -102.3% | -40.4% | -61.9% |
| ROA | -91.2% | -32.0% | -59.2% |
| Current Ratio | 10.46 | 2.84 | +7.62 |
| Debt / Equity | — | 0.28 | — |